Remaining ERC receivable of $1,772,744 (Q1-Q3)"Nova Leap’s US operating segment qualified for an ERC of $5,102,258 for the year ended December 31, 2021 which was recognized in Other income in the Consolidated Statement of Income and Comprehensive Income. To date, an amount of $3,329,514 has been received. The timing of collection of the remaining ERC receivable of $1,772,744 is unknown at this time."
Numbers and text from Year end financial statement: https://novaleaphealth.com/financial-statements/